DAFTAR PUSTAKA Potensi Interaksi Obat Antidepresan Di Rumah Sakit Jiwa Prof. Dr. Soerojo Magelang Periode Januari September Tahun 2015.
29
DAFTAR PUSTAKA
Anderson, I., 2000. Review : selective serotonin reuptake inhibitors are as
effective as tricyclic antidepressants overall but may be less effective in some
patient subgroups. Affect Disord 3, 2000.
Barton, M.K., 2011. Drug interactions in cancer patients receiving antidepressants
are common, researchers report. CA. Cancer J. Clin. 61, 283–284.
Bentue-Ferrer, D., Reymann, J., Tribut, O., Allain, H., Vasar, E., Bourin, M.,
2001. Role of dopaminergic and serotonergic systems on behavioral
stimulatory effects of low-dose alprazolam and lorazepam. Eur
Neuropsychopharmacol 11, 41–5.
Bishop, J.R., and Bishop, D.L., 2011. How to prevent serotonin syndrome from
drug-drug interactions. Curr. Psychiatr. 10, 81–83.
Coelho, P.V., and Brum, C.D.A., 2009. Interactions between antidepressants and
antihypertensive and glucose lowering drugs among patients in the
HIPERDIA Program, Coronel Fabriciano, Minas Gerais State, Brazil. Cad.
saude publica / Minist. da Saude, Fund. Oswaldo Cruz, Esc. Nac. Saude
Publica 25, 2229–2236.
Cooper, B.E., and Sejnowski, C.A., 2013. serotonin syndrome : Recognition and
Treatment. AACN Adv. Crit. Care 24, 15–20.
Darmayanti, N., 2002. Meta Analisis : Gender Dan Depresi Pada Remaja 35, pp.
164–180.
Evoy, G.K.M., 2008. American Society of health-system pharmacists formulary
service. Bethesda.
Ewald Howarth, Wainberg, M., Cournos, F., 2004. Psychiatric Medications and
HIV Antiretrovirals : A Guide to Interactions For Clinical. In: NY/NJ
AETC and the Columbia University HIV Mental Health Training Project.
Feighner, J., 1999. Mechanism of Action of Antidepressant Medications. J Clin
Psychiatry 4, 11.
Fuller, M., and Sajatoviv, M., 2002. Drug Information Handbook for Psychiatry.
Lexy Comp, Kanada.
Ganiswara, S.G., 2008. Farmakologi dan Terapi Edisi 5. FKUI, Jakarta.
Gitawati, R., 2008. Interaksi obat dan beberapaimplikasinya. Media Litbang
Kesehatan. XVIII, pp. 175–184.
30
Gupta, S.K., Shah, J.C., Hwang, S.S., 1999. Pharmacokinetic and
pharmacodynamic characterization of OROS A and immediate-release
amitriptyline 71–78.
Hansten, philip D., and Horn, J.R., 2000. Managing Clinically Important Drug
Interactions. Fact & Comparisions.
Helmyati, S., Rahmawati, Nur Farida, Purwanto, Yuliati, E., 2014. Interaksi Obat
dan Makanan. Gajah Mada University Press, Yogyakarta.
Hoan, T.T., Rahardja, K., 2015. Obat-obat Penting Khasiat, Penggunaan dan
Efek-efek Sampingnya, Edisi 7. ed. Pt. Gramedia, Jakarta.
Italiano, D., Spina, E., de Leon, J., 2014. Pharmacokinetic and pharmacodynamic
interactions between antiepileptics and antidepressants. Expert Opin. Drug
Metab. Toxicol. 10, 1457–89.
Kando, J.C., Teter, C.S., Wells, B.G., Hayes, P.E., 2007. Depressive Disorder
Pharmacoth. ed. Appleton and lange, New York.
Keller, M.B., and Shapiro, R.W., 1981. Major Depressive Disorder. J. Nerv.
Ment. Dis. 169, 761–768.
Lynch, T., and Price, A., 2007. The effect of cytochrome P450 metabolism on
drug response, interactions, and adverse effects. Am. Fam. Physician 76,
391–396.
Mann, J.J., 2005. The medical management of depression. N. Engl. J. Med. 353,
1819–1834.
Medscape,
2015.
Drug
Interaction
Cheker.
online.
http://www.reference.medscape.com/drug-interactionchecker
URL
Mental, H., 2011. Graylands Hospital Drug Bulletin Cytochromes and
Psychotripics. North Metrop. Area Heal. Serv. 18.
Mental, S., Hasharon, H., Mental, G., 2001. Post-Psychotic Depression in
Schizophrenia 3, 589–592.
Miguel, C., and Albuquerque, E., 2011. Drug interaction in psycho-oncology:
Antidepressants and antineoplastics. Pharmacology 88, 333–339.
Mihaljevic-Peles, A., Sagud, M., Bozina, N., Zivkovic, M., Jovanovic, N., 2009.
Pharmacogenetics and interactions of antidepressants in the treatment of comorbid illness. Psychiatr. Danub. 21, 399–400.
Moreau, A., Jones, B., Banno, J., 1986. Chronic central anticholinergic toxicity in
manic depressive illness mimicking dementia. Can J Psychiatry 31, 339–41.
31
Naibaho, D., 2008. Hubungan Interval QTc Memanjang Dengan Derajat
Disfungsi Hati pada. Uviversitas Sumatera Utara.
Notoatmodjo, S., 2005. Metode Penelitian Kesehatan. PT. Rineka Cipta, Jakarta.
Nugroho, A.E., 2012. Farmakologi: Obat-obat Penting dalam Pembelajaran Ilmu
Farmasis dan Dunia Kesehatan. Pustaka Belajar, Yogyakarta.
Okiyama, M., Ueno, K., S, O.I.T., Kitagawa, H., 1987. Drug interactions between
imipramine and benzodiazepines in rats. US Natl. Libr. Med. Natl. Institutes
Heal. 77(1):56-6.
Pieter, H.Z., Janiwarti, B., Ns. Marti Saragih, 2011. Pengantar Psikopatologi
untuk Keperawatan. Kencana, Jakarta.
Prayitno, 2008. Farmakologi Dasar. Lenskopi, Jakarta. pp.23.
Rahmawati, F., Handayani, R., Gosal, V., 2006. Kajian Retrospektif Interaksi
Obat di Rumah Sakit Pendidikan Dr. SardjitoYogyakarta. Maj. Farm.
Indones. 17, pp. 177–183.
Rao, N., 2007. The Clinical Pharmakokinetics of Escitalopram. Clin.
Pharmacokinet 46, 281–90.
Rasheed, A., Javed, M., Nazir, S., Khawaja, O., 1994. Interaction of
chlorpromazine with tricyclic anti-depressants in schizophrenic patients. J
Pak Med Assoc 44, 233–4.
Reus V.I., 2004. Mood Disorders dalam : Review of General Psychiatry.
McGraw Hill, Singapore. pp.27-35.
Sari, A., Wahyono, D., Raharjo, B., 2012. Identification Of Potential Drug
Interactions In Ward Patients At Margono Soekarjo Purwokerto ’S
Hospital : A Retrospective Observation. J. Ilm. Kefarmasian 2.
Sharpley, A.L., Vassallo, C.M., Cowen, P.J., 2000. Olanzapine increases slowwave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.
Biol Psychiatry 47, 468–470.
Snyder, B., Polasek, T., Doogue, M., 2012. Drug interactions: principles and
practice. Australian Prescriber.
Spina, E., and De Leon, J., 2007. Metabolic drug interactions with newer
antipsychotics: A comparative review. Basic Clin. Pharmacol. Toxicol. 100,
4–22.
Stockley, 2008. Stockley’s Drug Interaction, 8th Edition. Pharmaceutical Press.,
London.
32
Surbakti, R. br, 2014. Case Report A 30 Years Old Man With Depressed Type Of
Schizoaffective Disorder. J Medula Unila 3, 89–95.
Syamsudin, 2011. Interaksi Obat Konsep Dasar dan Klinis. Universitas Indonesia
(UI-Press), Jakarta.
Tatro, D., 2001. Drug Interaction Fact 6Ty edition, Facts Comparison. a Wolter
Kluwers, St Louis.
Tatro, D.., 2009. Drug Interaction Fact The Autority Drug Interactions, Fact And
Comparison. Wolter Kluwers, St Louis.
Teles, J.S., Fukuda, E.Y., Feder, D., 2012. Warfarin: pharmacological profile and
drug interactions with antidepressants. Einstein (São Paulo) 10, 110–115.
Unutzer, J., 2007. Late-Life Depression. N. Engl. J. Med. 2269–2276.
Walzer, M., Bekersky, I., Blum, R., Tolbert, D., 2012. Pharmacokinetic drug
interactions between clobazam and drugs metabolized by cytochrome P450
isoenzymes. Pharmacotherapy 32, 340–53.
Wenzel-Seifert, K., Wittmann, M., Haen, E., 2011. QTc prolongation by
psychotropic drugs and the risk of Torsade de Pointes. Dtsch. Arztebl. Int.
108, 687–93.
Yap, G., and Camm, A., 2003. Drug induced QT prolongation and Torsades de
Pointes. Heart 89, 1363–1372.
Yosep, I., 2010. Keperawatan Jiwa (Edisi Revisi). PT Refika Aditama, Bandung.
Young, C.R., Bowers, M.B., Mazure, C.M., 1998. Management of the adverse
effects of clozapine. Schizophr. Bull. 24, 381–390.
DAFTAR PUSTAKA
Anderson, I., 2000. Review : selective serotonin reuptake inhibitors are as
effective as tricyclic antidepressants overall but may be less effective in some
patient subgroups. Affect Disord 3, 2000.
Barton, M.K., 2011. Drug interactions in cancer patients receiving antidepressants
are common, researchers report. CA. Cancer J. Clin. 61, 283–284.
Bentue-Ferrer, D., Reymann, J., Tribut, O., Allain, H., Vasar, E., Bourin, M.,
2001. Role of dopaminergic and serotonergic systems on behavioral
stimulatory effects of low-dose alprazolam and lorazepam. Eur
Neuropsychopharmacol 11, 41–5.
Bishop, J.R., and Bishop, D.L., 2011. How to prevent serotonin syndrome from
drug-drug interactions. Curr. Psychiatr. 10, 81–83.
Coelho, P.V., and Brum, C.D.A., 2009. Interactions between antidepressants and
antihypertensive and glucose lowering drugs among patients in the
HIPERDIA Program, Coronel Fabriciano, Minas Gerais State, Brazil. Cad.
saude publica / Minist. da Saude, Fund. Oswaldo Cruz, Esc. Nac. Saude
Publica 25, 2229–2236.
Cooper, B.E., and Sejnowski, C.A., 2013. serotonin syndrome : Recognition and
Treatment. AACN Adv. Crit. Care 24, 15–20.
Darmayanti, N., 2002. Meta Analisis : Gender Dan Depresi Pada Remaja 35, pp.
164–180.
Evoy, G.K.M., 2008. American Society of health-system pharmacists formulary
service. Bethesda.
Ewald Howarth, Wainberg, M., Cournos, F., 2004. Psychiatric Medications and
HIV Antiretrovirals : A Guide to Interactions For Clinical. In: NY/NJ
AETC and the Columbia University HIV Mental Health Training Project.
Feighner, J., 1999. Mechanism of Action of Antidepressant Medications. J Clin
Psychiatry 4, 11.
Fuller, M., and Sajatoviv, M., 2002. Drug Information Handbook for Psychiatry.
Lexy Comp, Kanada.
Ganiswara, S.G., 2008. Farmakologi dan Terapi Edisi 5. FKUI, Jakarta.
Gitawati, R., 2008. Interaksi obat dan beberapaimplikasinya. Media Litbang
Kesehatan. XVIII, pp. 175–184.
30
Gupta, S.K., Shah, J.C., Hwang, S.S., 1999. Pharmacokinetic and
pharmacodynamic characterization of OROS A and immediate-release
amitriptyline 71–78.
Hansten, philip D., and Horn, J.R., 2000. Managing Clinically Important Drug
Interactions. Fact & Comparisions.
Helmyati, S., Rahmawati, Nur Farida, Purwanto, Yuliati, E., 2014. Interaksi Obat
dan Makanan. Gajah Mada University Press, Yogyakarta.
Hoan, T.T., Rahardja, K., 2015. Obat-obat Penting Khasiat, Penggunaan dan
Efek-efek Sampingnya, Edisi 7. ed. Pt. Gramedia, Jakarta.
Italiano, D., Spina, E., de Leon, J., 2014. Pharmacokinetic and pharmacodynamic
interactions between antiepileptics and antidepressants. Expert Opin. Drug
Metab. Toxicol. 10, 1457–89.
Kando, J.C., Teter, C.S., Wells, B.G., Hayes, P.E., 2007. Depressive Disorder
Pharmacoth. ed. Appleton and lange, New York.
Keller, M.B., and Shapiro, R.W., 1981. Major Depressive Disorder. J. Nerv.
Ment. Dis. 169, 761–768.
Lynch, T., and Price, A., 2007. The effect of cytochrome P450 metabolism on
drug response, interactions, and adverse effects. Am. Fam. Physician 76,
391–396.
Mann, J.J., 2005. The medical management of depression. N. Engl. J. Med. 353,
1819–1834.
Medscape,
2015.
Drug
Interaction
Cheker.
online.
http://www.reference.medscape.com/drug-interactionchecker
URL
Mental, H., 2011. Graylands Hospital Drug Bulletin Cytochromes and
Psychotripics. North Metrop. Area Heal. Serv. 18.
Mental, S., Hasharon, H., Mental, G., 2001. Post-Psychotic Depression in
Schizophrenia 3, 589–592.
Miguel, C., and Albuquerque, E., 2011. Drug interaction in psycho-oncology:
Antidepressants and antineoplastics. Pharmacology 88, 333–339.
Mihaljevic-Peles, A., Sagud, M., Bozina, N., Zivkovic, M., Jovanovic, N., 2009.
Pharmacogenetics and interactions of antidepressants in the treatment of comorbid illness. Psychiatr. Danub. 21, 399–400.
Moreau, A., Jones, B., Banno, J., 1986. Chronic central anticholinergic toxicity in
manic depressive illness mimicking dementia. Can J Psychiatry 31, 339–41.
31
Naibaho, D., 2008. Hubungan Interval QTc Memanjang Dengan Derajat
Disfungsi Hati pada. Uviversitas Sumatera Utara.
Notoatmodjo, S., 2005. Metode Penelitian Kesehatan. PT. Rineka Cipta, Jakarta.
Nugroho, A.E., 2012. Farmakologi: Obat-obat Penting dalam Pembelajaran Ilmu
Farmasis dan Dunia Kesehatan. Pustaka Belajar, Yogyakarta.
Okiyama, M., Ueno, K., S, O.I.T., Kitagawa, H., 1987. Drug interactions between
imipramine and benzodiazepines in rats. US Natl. Libr. Med. Natl. Institutes
Heal. 77(1):56-6.
Pieter, H.Z., Janiwarti, B., Ns. Marti Saragih, 2011. Pengantar Psikopatologi
untuk Keperawatan. Kencana, Jakarta.
Prayitno, 2008. Farmakologi Dasar. Lenskopi, Jakarta. pp.23.
Rahmawati, F., Handayani, R., Gosal, V., 2006. Kajian Retrospektif Interaksi
Obat di Rumah Sakit Pendidikan Dr. SardjitoYogyakarta. Maj. Farm.
Indones. 17, pp. 177–183.
Rao, N., 2007. The Clinical Pharmakokinetics of Escitalopram. Clin.
Pharmacokinet 46, 281–90.
Rasheed, A., Javed, M., Nazir, S., Khawaja, O., 1994. Interaction of
chlorpromazine with tricyclic anti-depressants in schizophrenic patients. J
Pak Med Assoc 44, 233–4.
Reus V.I., 2004. Mood Disorders dalam : Review of General Psychiatry.
McGraw Hill, Singapore. pp.27-35.
Sari, A., Wahyono, D., Raharjo, B., 2012. Identification Of Potential Drug
Interactions In Ward Patients At Margono Soekarjo Purwokerto ’S
Hospital : A Retrospective Observation. J. Ilm. Kefarmasian 2.
Sharpley, A.L., Vassallo, C.M., Cowen, P.J., 2000. Olanzapine increases slowwave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.
Biol Psychiatry 47, 468–470.
Snyder, B., Polasek, T., Doogue, M., 2012. Drug interactions: principles and
practice. Australian Prescriber.
Spina, E., and De Leon, J., 2007. Metabolic drug interactions with newer
antipsychotics: A comparative review. Basic Clin. Pharmacol. Toxicol. 100,
4–22.
Stockley, 2008. Stockley’s Drug Interaction, 8th Edition. Pharmaceutical Press.,
London.
32
Surbakti, R. br, 2014. Case Report A 30 Years Old Man With Depressed Type Of
Schizoaffective Disorder. J Medula Unila 3, 89–95.
Syamsudin, 2011. Interaksi Obat Konsep Dasar dan Klinis. Universitas Indonesia
(UI-Press), Jakarta.
Tatro, D., 2001. Drug Interaction Fact 6Ty edition, Facts Comparison. a Wolter
Kluwers, St Louis.
Tatro, D.., 2009. Drug Interaction Fact The Autority Drug Interactions, Fact And
Comparison. Wolter Kluwers, St Louis.
Teles, J.S., Fukuda, E.Y., Feder, D., 2012. Warfarin: pharmacological profile and
drug interactions with antidepressants. Einstein (São Paulo) 10, 110–115.
Unutzer, J., 2007. Late-Life Depression. N. Engl. J. Med. 2269–2276.
Walzer, M., Bekersky, I., Blum, R., Tolbert, D., 2012. Pharmacokinetic drug
interactions between clobazam and drugs metabolized by cytochrome P450
isoenzymes. Pharmacotherapy 32, 340–53.
Wenzel-Seifert, K., Wittmann, M., Haen, E., 2011. QTc prolongation by
psychotropic drugs and the risk of Torsade de Pointes. Dtsch. Arztebl. Int.
108, 687–93.
Yap, G., and Camm, A., 2003. Drug induced QT prolongation and Torsades de
Pointes. Heart 89, 1363–1372.
Yosep, I., 2010. Keperawatan Jiwa (Edisi Revisi). PT Refika Aditama, Bandung.
Young, C.R., Bowers, M.B., Mazure, C.M., 1998. Management of the adverse
effects of clozapine. Schizophr. Bull. 24, 381–390.